Paradigm Shift

In Cancer Treatment

Learn More

News & Events

January 6-10, 2019

Salarius is attending the 36th Annual healthcare conference. JP Morgan is the premier investor conference and we are excited to be attending once again.

If you plan on attending and would like an introduction or a chance to meet with the Salarius Team, please contact dsantiesteban@salariuspharma.com

December 12, 2018 @ 10:00am Pacific

Salarius presents the significant progress made in 2H2018.  Announces Goals for 2019 which include completing Phase 1 dose escalation in Ewing Sarcoma and initiating a phase 1 Advanced Solid Tumor study.

Keiretsu Forum represents a global investment community of accredited private equity angel investors, venture capitalists and corporate/institutional investors. Keiretsu Forum is a worldwide network of capital, resources and deal flow with 52 chapters on 3 continents. Keiretsu Forum members invest in high-quality, diverse investment opportunities.

Dr. Dugan comes to us with 20 years experience in oncology clinical research. She is Board certified medical oncologist and hematologist from New York University Fellowship Program, with MD degree from New York University School of Medicine.